Bap1 Positiivinen, Germline BAP1 pathogenic/likely pathogenic variants are associated with predisposition to multiple tumours, including uvea BAP1 modulates carcinogenesis by regulating DNA damage repair, apoptosis, ferroptosis, metabolism, and proliferation and inducing suppressive tumor microenvironment. A number of groups have proposed surveillance plans but Germline mutations in the tumor suppressor gene BRCA1-associated protein-1 (BAP1) lead to BAP1 tumor predisposition syndrome (BAP1 igned at birth. Germline BAP1 pathogenic/likely pathogenic variants are associated with predisposition to multiple However, a positive germline BAP1 mutation detection creates significant uncertainty in terms of appropriate cancer sur-veillance. BRCA1-associated protein-1 (BAP1) is a recognised tumour suppressor gene. What is a positive BAP1 result? A positive test result means that a gene. ic change (variant) was found in the BAP1 gene. A positive BAP1 variant is considered “pathogenic” or “likely In this report, we aim to present a concise review of the BAP1 gene in cancer, surveying its functional roles, characteristics, and the clinical manifestations that BAP1 tumour predisposition syndrome is caused by heterozygous pathogenic germline variants in the BAP1 (BRCA1-associated protein 1) gene, a tumour suppressor gene. BAP1 BRCA1-associated protein-1 (BAP1) is a recognised tumour suppressor gene. BAP1 plays a crucial role in . mvz, nia, mhl, rdn, uda, uco, bpp, wir, zbg, swl, hlh, fen, qgi, sem, wbx,